This article needs additional citations for verification. (April 2013) (Learn how and when to remove this template message)
|AHFS/Drugs.com||Consumer Drug Information|
|Chemical and physical data|
|Molar mass||383.405 g/mol|
Ceftizoxime is a third-generation cephalosporin available for parenteral administration. Unlike other third-generation cephalosporins, the whole C-3 side chain in ceftizoxime has been removed to prevent deactivation by hydrolytic enzymes. It rather resembles cefotaxime in its properties, but is not subject to metabolism. It was removed from the US Market in 2007.
|This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it.|